Clinical trial
An Open-Label Preference Evaluation of BLI800
Name
BLI800-491
Description
The purpose of this study is to evaluate patient experience ratings of BLI800 in adult patients undergoing colonoscopy.
Trial arms
Trial start
2019-09-24
Estimated PCD
2019-11-21
Trial end
2019-11-21
Status
Completed
Phase
Early phase I
Treatment
BLI800
BLI800 Bowel Preparation
Arms:
BLI800
Size
40
Primary endpoint
Ease of Preparation Consumption
2 days
Eligibility criteria
Primary Inclusion Criteria:
* Male or female outpatients who are undergoing colonoscopy for a routinely accepted indication
* 18 to 85 years of age (inclusive)
* If female, and of child-bearing potential, is using an acceptable form of birth control
* Negative urine pregnancy test at screening, if applicable
* In the Investigator's judgment, subject is mentally competent to provide informed consent to participate in the study
Primary Exclusion Criteria:
* Subjects with known or suspected ileus, severe ulcerative colitis, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis or megacolon
* Subjects with ongoing severe, acute inflammatory bowel disease
* Subjects who had previous significant gastrointestinal surgeries
* Subjects with known severe renal, hepatic or cardiac insufficiency
* Subjects undergoing insulin therapy for any indication
* Subjects with impaired consciousness that predisposes them to pulmonary aspiration
* Subjects undergoing colonoscopy for foreign body removal and/or decompression
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE4'], 'designInfo': {'allocation': 'NA', 'interventionModel': 'SINGLE_GROUP', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 40, 'type': 'ACTUAL'}}
Updated at
2023-10-23
1 organization
1 product
1 indication
Organization
Braintree LaboratoriesProduct
BLI800Indication
Colonoscopy